Most interestingly, the presence of ERCC1pos CTCs at primary diagnosis was an independent predictor for platinum-resistance whereas ERCC1-expression in the corresponding primary tumor tissue predicted neither platinum-resistance, nor prognosis [35]. Here, ERCC1 is linked to neoplasm.